Get started
Author

Yuko Nagaoki

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs
2021 · Heather J. Cordell, James J. Fryett, et al. · Journal of Hepatology · 185
Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis
2017 · Yuko Nagaoki, Hiroshi Aikata, et al. · Hepatology Research · 152
Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease
2017 · Takashi Nakahara, Hideyuki Hyogo, et al. · Journal of Gastroenterology · 130
Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma
2012 · Yohji Honda, Tomoki Kimura, et al. · Journal of Gastroenterology and Hepatology · 99
Recent trend of clinical features in patients with hepatocellular carcinoma
2011 · Yuko Nagaoki, Hideyuki Hyogo, et al. · Hepatology Research · 94
Evaluation of the mRECIST and α-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib
2012 · Tomokazu Kawaoka, Hiroshi Aikata, et al. · Oncology · 70
Utility of controlled attenuation parameter measurement for assessing liver steatosis in J apanese patients with chronic liver diseases
2013 · Keiichi Masaki, Shintaro Takaki, et al. · Hepatology Research · 69
PDF
Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large‐scale, long‐term cohort study
2015 · Yuko Nagaoki, Hiroshi Aikata, et al. · Journal of Gastroenterology and Hepatology · 60
The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy
2017 · Yuko Nagaoki, Michio Imamura, et al. · PLoS ONE · 57
PDF
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis
2021 · Rosanna Asselta, Elvezia M. Paraboschi, et al. · Gastroenterology · 56
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to C hild– P ugh classification
2012 · Daisuke Miyaki, Hiroshi Aikata, et al. · Journal of Gastroenterology and Hepatology · 56
Evaluation of glycemic variability in chronic liver disease patients with type 2 diabetes mellitus using continuous glucose monitoring
2018 · Fumi Honda, Akira Hiramatsu, et al. · PLoS ONE · 54
Preoperative Fluorine 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Prediction of Microvascular Invasion in Small Hepatocellular Carcinoma
2016 · Tomoki Kobayashi, Hiroshi Aikata, et al. · Journal of Computer Assisted Tomography · 42
The impact of interferon‐free direct‐acting antivirals on clinical outcome after curative treatment for hepatitis C virus–associated hepatocellular carcinoma: Comparison with interferon‐based therapy
2018 · Yuko Nagaoki, Michio Imamura, et al. · Journal of Medical Virology · 38
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study
2021 · Yuko Nagaoki, Hideyuki Hyogo, et al. · BMC Gastroenterology · 36
PDF
Management of undifferentiated sarcoma of the liver including living donor liver transplantation as a backup procedure
2009 · Hideaki Okajima, Yuki Ohya, et al. · Journal of Pediatric Surgery · 33
Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury
2017 · Kei Morio, Michio Imamura, et al. · Journal of Gastroenterology · 32
Hepatic arterial infusion chemotherapy using 5‐fluorouracil and systemic interferon‐α for advanced hepatocellular carcinoma in combination with or without three‐dimensional conformal radiotherapy to venous tumor thrombosis in hepatic vein or inferior vena cava
2011 · Eisuke Murakami, Hiroshi Aikata, et al. · Hepatology Research · 31
Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients
2020 · Yuko Nagaoki, Michio Imamura, et al. · Hepatology Research · 26
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
2018 · Masahiro Hatooka, Tomokazu Kawaoka, et al. · BMC Cancer · 25
PDF
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy
2017 · Kazuhiko Masuda, Atsushi Ono, et al. · Journal of Gastroenterology · 25
PDF
Clinical features and prognosis in patients with hepatocellular carcinoma that developed after hepatitis C virus eradication with interferon therapy
2011 · Yuko Nagaoki, Hiroshi Aikata, et al. · Journal of Gastroenterology · 25
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma
2017 · Yuji Teraoka, Tomoki Kimura, et al. · Hepatology Research · 23
Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C
2013 · Hiroshima Liver Study Group, Hatsue Fujino, et al. · Journal of Gastroenterology · 23
ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C
2016 · Kei Morio, Michio Imamura, et al. · Journal of Gastroenterology · 22
Works count: 80
Citation count: 1,850
H-index: 23
I10-index: 43
Year
Topic
Type